Your browser doesn't support javascript.
Thromboprophylaxis in Patients with COVID-19: Systematic Review of National and International Clinical Guidance Reports.
Kyriakoulis, Konstantinos G; Kollias, Anastasios; Kyriakoulis, Ioannis G; Kyprianou, Ioanna A; Papachrysostomou, Chrysso; Makaronis, Panagiotis; Kotronias, Rafail A; Terentes-Printzios, Dimitrios; Toskas, Ioannis; Mikhailidis, Dimitri P.
  • Kyriakoulis KG; Third Department of Medicine, National and Kapodistrian University of Athens, School of Medicine, Sotiria Hospital, Athens, Greece.
  • Kollias A; Third Department of Medicine, National and Kapodistrian University of Athens, School of Medicine, Sotiria Hospital, Athens, Greece.
  • Kyriakoulis IG; Faculty of Medicine, School of Health Science, University of Thessaly, Larissa, Greece.
  • Kyprianou IA; School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Papachrysostomou C; Department of Cardiology, General Hospital of Athens "G. Gennimatas", Athens, Greece.
  • Makaronis P; Department of Cardiology, General Hospital of Athens "G. Gennimatas", Athens, Greece.
  • Kotronias RA; Department of Cardiovascular Medicine, University of Oxford, Oxford, UK.
  • Terentes-Printzios D; Oxford Heart Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, Oxfordshire, UK.
  • Toskas I; Departmentof Cardiology and Angiology, Faculty of Medicine of the Eberhard Karls University Tübingen, Tübingen, Germany.
  • Mikhailidis DP; Department of Clinical Biochemistry, Royal Free Hospital Campus, University College London Medical School, University College London (UCL), UK.
Curr Vasc Pharmacol ; 20(1): 96-110, 2022.
Article in English | MEDLINE | ID: covidwho-1372047
ABSTRACT

BACKGROUND:

Venous Thromboembolism (VTE) is common among patients with severe Coronavirus Disease 2019 (COVID-19). Anticoagulation in hospitalized COVID-19 patients has been associated with survival benefit; however, the optimal thromboprophylaxis strategy has not yet been defined.

OBJECTIVE:

To identify published guidance reports by national and international societies regarding thromboprophylaxis strategies in COVID-19 patients in different settings (outpatients, hospitalized, post-discharge).

METHODS:

A systematic review of the literature (Pubmed/EMBASE) was conducted independently by two investigators.

RESULTS:

Among 1942 initially identified articles, 33 guidance documents were included 20 published by national and 13 by international societies. These documents provide recommendations mainly for hospitalized (97% of reports) and post-discharge (75%) COVID-19 patients, and less so for outpatients (34%). Thrombotic and bleeding risk stratification prior to any treatment decision is the cornerstone of all suggested thromboprophylaxis strategies; 81% of the documents recommend thromboprophylaxis for all hospitalized patients with a prophylactic dosage of low molecular weight heparin irrespective of VTE risk. Intermediate or therapeutic dose intensity is recommended in high VTE risk patients by 56% and 28% of documents, respectively. Mechanical thromboprophylaxis is suggested in case of high bleeding risk or contraindication to pharmacological thromboprophylaxis (59% of documents). Extended pharmacological thromboprophylaxis is recommended for patients with high VTE risk after hospital discharge (63% of documents). For non-hospitalized outpatients, 28% of documents recommend pharmacological thromboprophylaxis for high VTE risk.

CONCLUSION:

The current guidance identifies thromboprophylaxis in COVID-19 patients, especially during hospitalization, as of major importance for the prevention of VTE. Recommendations are derived from limited evidence from observational studies.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Venous Thromboembolism / COVID-19 Type of study: Cohort study / Observational study / Prognostic study / Reviews / Systematic review/Meta Analysis Topics: Long Covid Limits: Humans Language: English Journal: Curr Vasc Pharmacol Journal subject: Vascular Diseases / Pharmacology Year: 2022 Document Type: Article Affiliation country: 1570161119666210824160332

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Venous Thromboembolism / COVID-19 Type of study: Cohort study / Observational study / Prognostic study / Reviews / Systematic review/Meta Analysis Topics: Long Covid Limits: Humans Language: English Journal: Curr Vasc Pharmacol Journal subject: Vascular Diseases / Pharmacology Year: 2022 Document Type: Article Affiliation country: 1570161119666210824160332